Breast Cancer News and Research

Latest Breast Cancer News and Research

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

Researchers find way to get beneficial effects of estrogen without increasing woman's risk of cancer

Researchers find way to get beneficial effects of estrogen without increasing woman's risk of cancer

UK cancer survival rates increase at 3% each year

UK cancer survival rates increase at 3% each year

Toshiba announces availability of Aegis breast imaging workstation with MR products

Toshiba announces availability of Aegis breast imaging workstation with MR products

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

Recent objections would eliminate use of routine breast cancer screening mammograms: Authors

Recent objections would eliminate use of routine breast cancer screening mammograms: Authors

Cancer forms “intolerable burden” on the community: Health Minister

Cancer forms “intolerable burden” on the community: Health Minister

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

FDA Advisory Committee recommendation against flibanserin will not affect LibiGel program: BioSante

FDA Advisory Committee recommendation against flibanserin will not affect LibiGel program: BioSante

Al Amal Hospital in Qatar commences treatment with Varian's RapidArc radiotherapy

Al Amal Hospital in Qatar commences treatment with Varian's RapidArc radiotherapy

Independent DMC recommends continuation of BioSante's ongoing LibiGel CV and Breast Cancer Safety Study

Independent DMC recommends continuation of BioSante's ongoing LibiGel CV and Breast Cancer Safety Study

Dako, Omnyx partner to develop clinical algorithms for digital pathology

Dako, Omnyx partner to develop clinical algorithms for digital pathology

ZIOPHARM Oncology announces guidance on palifosfamide Phase III trial in metastatic soft tissue sarcoma

ZIOPHARM Oncology announces guidance on palifosfamide Phase III trial in metastatic soft tissue sarcoma

EIN News expands health news-monitoring coverage

EIN News expands health news-monitoring coverage

Consumers can now access high quality health and medical information on Internet using Medgateway.com

Consumers can now access high quality health and medical information on Internet using Medgateway.com

Prototype drug blocks MCL-1 protein that helps tumors survive treatment: Scientists

Prototype drug blocks MCL-1 protein that helps tumors survive treatment: Scientists

New phase I/IIa clinical trial of AR-42 for blood cancer at OSUCCC-James

New phase I/IIa clinical trial of AR-42 for blood cancer at OSUCCC-James

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

FVL gene mutation increases risk of blood clots in breast cancer patients treated with tamoxifen: Study

FVL gene mutation increases risk of blood clots in breast cancer patients treated with tamoxifen: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.